Hızlı Erişim


Bu Dergi DOI ve Crosscheck üyesidir


Abstract


LIVEDO RETICULARIS: CLINICAL SIGNIFICANCE AND TREATMENT

Livedo reticularis (LR) is a hyperpigmented discoloration of the skin characterized by a violet, reticulated cyanotic pattern, and is more common on the extremities and trunk. LR is in the form of intact circular networks. If the circular reticulated appearance is distorted and shows an irregular fracture pattern, it is defined as livedo racemosa (LRC). LR is a benign, primary disease that affects young and middle-aged women. LRC, on the other hand, is a secondary disease, pathological and permanent. In LR, the vivid cone discoloration is symmetrical, reversible, and uniform. In LRC, the vivid cone discoloration is irreversible, and fractured. Although it has been stated as a concept that the pathological livedoid form is LCR, there is no clear distinction between LR and LRC in clinical studies and generally 'livedo reticularis' is used to describe both. Our study includes eight patients diagnosed with livedo reticularis between January 2013 and May 2021. One of our patients was male and the other was female. Their ages ranged from 25 to 70 years and the mean age was 45.5±16.7 years. Although the main complaints were coldness, numbness and pain, aesthetic anxiety was prominent in all patients. On physical examination, violet-colored fishing net-like appearances were noted on the lower extremities of all patients. It was accompanied by venous insufficiency in six of the patients. As a result of the treatment we applied, there was improvement in venous insufficiency. However, as a result of the vasodilator treatment we applied for cosmological purposes, there was no obvious improvement in the reticulated appearances. Because of the risk of developing neurovascular and cardiovascular complications several years after the onset of livedoid vasculopathy, it is important to monitor these patients. Considering that LR may be seen before pulmonary symptoms during the COVID-19 pandemic period, necessary tests should be performed to rule out the diagnosis of COVID-19 in these cases.



Keywords
Livedo Reticularis, Livedo Racemosa, Livedoid Vasculopathy



Kaynakça 1. Alavi A, Hafner J, Dutz JP, Mayer D, Sibbald RG, Criado PR, et al. Livedoid vasculopathy: an in-depth analysis using a modified Delphi approach. J Am Acad Dermatol. 2013 Dec;69(6):1033-1042. 2. Amitai DB, Fichman S, Merlob P, Morad Y, Lapidoth M, Metzker A. Cutis marmorata telangiectatica congenita: clinical findings in 85 patients. Pediatr Dermatol. 2000;17(2):100-4. doi: 10.1046/j.1525-1470.2000.01723.x. PMID: 10792796. 3. Basaranoğlu G, İdin K, Umutoğlu T, Esen A, Bakan M. Livedoid vasculopaty and anesthetic management in cedsarean delivery. Bakırköy Tıp Derg 2016;12(4):224-226. 4. Dean SM. Livedo reticularis and related disorders. Curr Treat Options Cardiovasc Med. 2011 Apr;13(2):179-91. doi: 10.1007/s11936-011-0115-z. PMID: 21287303. 5. González-Moure C, Casas-Fernández L, Molinos-Castro S, Varela-García PM, Suárez-Peñaranda JM. Cardiac myxoma presenting as relapsing livedo reticularis. Int J Dermatol. 2021 Apr 20. doi: 10.1111/ijd.15608. Epub ahead of print. PMID: 33880772. 6. Gonzalez-Santiago TM, Davis MD. Update of management of connective tissue diseases: Livedoid vasculopathy: further evidence for procoagulant pathogenesis. Arch Dermatol 2006:142;1413-1418. 7. Gottlieb M, Long B. Dermatologic manifestations and complications of COVID-19. Am J Emerg Med. 2020;38(9):1715-1721. doi: 10.1016/j.ajem.2020.06.011. 8. Goyal P, Dayal S, Sahu P. Generalized Livedo Reticularis: A Rare Variety. Indian J Dermatol. 2019 Jan-Feb;64(1):59-61. doi: 10.4103/ijd.IJD_246_18. PMID: 30745637; PMCID: PMC6340240. 9. Kadan M, Karabacak K, Kaya E. Vazospastik damar hastalıkları. Damar Cer Derg 2013;22(2):225-237. 10. Maessen-Visch MB, Koedam MI, Hamulyák K, Neumann HA. Atrophie blanche. Int J Dermatol. 1999;38:161–72. 11. Özdemir Ö, Pala AA, Şeker E. Dermatological manifestations in COVID-19 disease. Sakarya Med J. 2021: 11(1):282-220. 12. Rose AE, Saggar V, Boyd KP, Patel RR, and McLellan B. Dermatology Online Journal. 2013;9(12):1. 13. Sajjan VV, Lunge S, Swamy MB, Pandit AM. Livedo reticularis: A review of the literature. Indian Dermatol Online J. 2015 Sep-Oct;6(5):315-21. doi: 10.4103/2229-5178.164493. PMID: 26500860; PMCID: PMC4594389. 14. Sancıoğlu H, Gürçay E, Karaahmet ÖZ, Çakcı A. factor V Leiden mutation associated with Sneddon syndrome. J Clin Analytic Med. DOI: 10.4328/JCAM.2006. 15. Sangle SR and D’Cruz DP. Livedoid vasculopathy: an enigma. IMAJ 2015;17:104-107. 16. Toubi E, Krause I, Fraser A, Lev S, Stojanovich L, Rovensky J, et al. Livedo reticularis is a marker for predicting multi-system thrombosis in antiphospholipid syndrome. Clin Exp Rheumatol. 2005 Jul-Aug;23(4):499-504. PMID: 16095119. 17. Uthman IW, Khamashta MA. Livedo racemosa: a striking dermatological sign for the antiphospholipid syndrome. J Rheumatol. 2006;33(12):2379-82.

Gelişmiş Arama


Duyurular

    ***********************

    DEĞERLİ BİLİM 

    İNSANLARI!

    mail mail mail mail mail

    Dergimizin Kasım sayısı 

    (25.11.2021)

    yayınlanmıştır.

    mail mail mail mail mail

    DEĞERLİ BİLİM 

    İNSANLARI!

    mail mail mail mail mail

    Dergimizin

    Aralık Sayısı 

    İçin Makalenizi  

    Sisteme Yükleyebilirsiniz.

    mail mail mail mail mail

     



Adres :Göztepe Mah., Beykoz, İstanbul/TURKEY
Telefon : Whatsapp: +90 555 005 92 85 Faks :+90 216 606 32 75
Eposta :info@euroasiajournal.org

Web Yazılım & Programlama Han Yazılım Bilişim Hizmetleri